Diode laser in synergy with pharmacological therapy in treatment of OSMF

---

Case Report

Author Details : Nikita N Burde*, Gayathri S

Volume : 10, Issue : 1, Year : 2022

Article Page : 27-30

https://doi.org/10.18231/j.jds.2022.007

Suggest article by email

Get Permission

---

Abstract

Oral submucous fibrosis (OSMF) leads to progressive limitation in the opening of the mouth and protrusion of the tongue, thus causing difficulty in eating, swallowing, and phonation. The treatment modalities include both pharmacological and surgical modes of treatment. To achieve adequate mouth opening, the complete release of fibrotic tissue is essential. Pharmacological therapy is useful only in the initial stages while surgical therapy is used in later stages of the disease. Incising the fibrotic tissue with a conventional blade or electrocautery can cause further fibrosis. Laser excision comparatively leads to lesser intraoperative bleeding hence better vision, faster healing of tissues, and least or no post-operative scarring.
 

Keywords: Diode laser, Lycopene, Oral submucous fibrosis, Trismus

How to cite : Burde N N, Gayathri S, Diode laser in synergy with pharmacological therapy in treatment of OSMF. J Dent Spec 2022;10(1):27-30

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.